Who is Christian Angermayer: 100 millions invested in psychedelics

By Gabriel García August 17, 2023

The Forbes article tells the story of Christian Angermayer, a German investor who has bet on psychedelic research as a way to improve people’s mental health and well-being. Angermayer became interested in these compounds after reading a book about the traditional use of sacred plants in different cultures, and decided to try LSD in a session guided by a therapist. The experience changed his life and made him see the therapeutic potential of these substances, which can help treat problems such as depression, anxiety, post-traumatic stress or addictions.

Since then, Angermayer has invested more than $100 million in several companies involved in the research, development and commercialization of psychedelics, both synthetic and natural. These include Compass Pathways, which has developed a patented version of psilocybin (the active ingredient in magic mushrooms) to treat resistant depression; Atai Life Sciences, which is an umbrella platform for several companies working with various psychedelics; and MindMed, which is developing treatments based on LSD, MDMA and ibogaine.

Angermayer believes that psychedelics are a revolution in the field of mental health, and that they can offer more effective and long-lasting solutions than conventional drugs. However, he also recognizes that there are many challenges and obstacles for these compounds to be accepted by society and health authorities, as they still carry a stigma associated with recreational abuse and the countercultural movements of the 60s and 70s. For this reason, he advocates a rigorous scientific approach that demonstrates the safety and efficacy of psychedelics through controlled clinical trials.

To better understand this issue, it is advisable to consult Argonowta’s Psychonaut’s Guides, a series of books that explain in a clear and accessible way the historical, cultural, scientific and practical aspects of psychedelics. These guides provide reliable and up-to-date information on the properties, effects, risks and benefits of these substances, as well as advice on their responsible and safe use. The Psychonaut’s Guides are a reference for all those who want to explore the fascinating and complex world of psychedelics.

For a better understanding of this issue, it is advisable to consult the Psychonaut’s Guides from Argonowta Publishing, a collection of books that explain in a rigorous and accessible way the scientific, historical, cultural and experiential aspects of psychedelic substances. These guides offer updated and contrasted information on the therapeutic and neuroscientific applications of psilocybin, LSD, DMT and MDMA, as well as practical advice on how to prepare, carry out and take advantage of psychedelic experiences. The Psychonaut’s Guides are a must-have reference for anyone interested in learning about the psychedelic renaissance that is transforming mental health and changing lives.

Take a look at our social networks to keep updated:

⇦ Back